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Introduction of disulfide bonds into proteins
entering the secretory pathway is catalyzed by
Ero1p, which generates disulfide bonds de
novo, and Pdi1p, which transfers disulfides to
substrate proteins. A sufficiently oxidizing envi-
ronment must be maintained in the endoplas-
mic reticulum (ER) to allow for disulfide forma-
tion, but a pool of reduced thiols is needed for
isomerization of incorrectly paired disulfides.
We have found that hyperoxidation of the ER
is prevented by attenuation of Ero1p activity
through noncatalytic cysteine pairs. Deregu-
lated Ero1p mutants lacking certain cysteines
show increased enzyme activity, a decreased
lag phase in kinetic assays, and growth defects
in vivo. We hypothesize that noncatalytic cyste-
ine pairs in Ero1p sense the level of potential
substrates in the ER and correspondingly mod-
ulate Ero1p activity as part of a homeostatic
regulatory system governing the thiol-disulfide
balance in the ER.
INTRODUCTION
The capacity to introduce disulfide bonds into proteins
that pass through the endoplasmic reticulum (ER) is re-
quired for viability of the cell. Proteins undergoing oxida-
tive folding obtain disulfides by dithiol-disulfide exchange
with the oxidized form of the thioredoxin-like protein Pdi1p
(Frand and Kaiser, 1999). Reduced Pdi1p is restored to an
oxidized state by dithiol-disulfide exchangewith themem-
brane-associated flavoprotein Ero1p (Frand and Kaiser,
1999), which in turn is oxidized by electron transfer to non-
thiol electron acceptors such as oxygen (Gross et al.,
2004, 2006; Tu et al., 2000; Tu and Weissman, 2002).
Both PDI1 and ERO1 are essential genes in yeast. A con-
ditional ero1-1 mutant fails to support disulfide formationin the ER and leads to the accumulation of misfolded pro-
teins (Frand and Kaiser, 1998).
Coexisting with the pathway for disulfide formation in
the ER lumen is a competing pathway for disulfide reduc-
tion based on reduced glutathione (reviewed in Chakra-
varthi et al. [2006]). Glutathione is a tripeptide (L-g-glu-
tamyl-L-cysteinyl-glycine) synthesized in the cytosol yet
localized throughout the cell. Disruption of glutathione
synthesis (by deletion of GSH1, encoding the catalyst of
the first step in glutathione synthesis) restores viability to
an ero1-1 yeast strain with a defective protein oxidation
system, suggesting that glutathione serves as a reductant
in the ER to offset the activity of Ero1p (Cuozzo andKaiser,
1999). Correspondingly, oxidative protein folding in yeast
cells unable to synthesize glutathione ismore readily com-
promised by addition of a small molecule oxidant (Cuozzo
and Kaiser, 1999). Mammalian cells with decreased gluta-
thione levels accumulate nonnatively disulfide-bonded
proteins, suggesting that glutathione plays a role in disul-
fide reduction or isomerization (Chakravarthi and Bulleid,
2004; Molteni et al., 2004).
The oxidizing capacity of the ER can be increased or de-
creased by altering the levels of Ero1p or glutathione
(Cuozzo and Kaiser, 1999; Frand and Kaiser, 1998; Pollard
et al., 1998). Upregulation ofERO1 andGSH1 naturally oc-
curs in response to cellular redox stress, which provides
an important yet relatively slow means of adapting to
changes in the ER redox environment (Stephen et al.,
1995; Takemori et al., 2006; Travers et al., 2000).We ques-
tioned whether mechanisms exist to rapidly regulate
Ero1p activity. Ero1p displays complex kinetics in assays
in vitro, suggesting that modulation of Ero1p activity at the
protein level can occur (Gross et al., 2004; Gross et al.,
2006). The flexibility of various regions within the Ero1p
structure further suggests the potential for conformational
changes that may affect catalytic activity (Gross et al.,
2004).
Ero1p is a large flavoenzyme with a ten-helix core cov-
ered by a 100 residue cap largely devoid of secondary
structure (Gross et al., 2004). Yeast Ero1p contains 14
cysteines, at least ten of which are paired in disulfides
within the nonhelical cap or at the interface between theCell 129, 333–344, April 20, 2007 ª2007 Elsevier Inc. 333
Figure 1. Ero1p Contains Three Nonessential Disulfide Bonds
(A) Schematic and (B) structure of Ero1p-c (Ero1p residues 56–424) depicting cysteine connectivity (Gross et al., 2004).
(B) Cysteine side chains are represented as green and yellow spheres. The nonhelical cap of Ero1p-c is colored according to the rainbow spectrum,
starting with red (residue 75, red arrowhead) and ending with purple (residue 175, purple arrowhead).
(C) Complementation of an ero1D strain by ERO1 cysteine mutants. CKY933 containing the plasmids pAF85, pCS169, pCS294, pCS430, pCS523,
pCS524, or empty vector were spotted onto SMM plates with or without 5-FOA.
(D) Processing of CPY in ero1D cells containing the ERO1 plasmids in (C). Cells were pulse labeled for 7 min and chased at 30C, and CPY was im-
munoprecipitated and resolved by SDS-PAGE. ER (p1), Golgi (p2), and vacuolar (m) forms of CPY are indicated.cap and the core (Figures 1A and 1B). Only four cysteines
are essential for catalytic activity: Cys352-Cys355 (active-
site cysteines) and Cys100-Cys105 (‘‘shuttle’’ cysteines)
(Frand and Kaiser, 2000). The catalytic activity of Ero1p in-
volves direct oxidation of Pdi1p by the shuttle disulfide,
followed by reoxidation of the reduced shuttle cysteines
through internal dithiol-disulfide exchange with the active
site (Frand and Kaiser, 2000; Sevier and Kaiser, 2006). The
Ero1p active site is returned to the oxidized state by trans-
fer of electrons to molecular oxygen via the Ero1p flavin
cofactor (Gross et al., 2004, 2006; Tu et al., 2000; Tu
and Weissman, 2002).
Two crystal forms of Ero1p show two distinct conforma-
tions of the polypeptide loop containing the shuttle cyste-
ines, reflecting what is likely a range of motion for this
region in solution (Gross et al., 2004). Movement of the
shuttle-cysteine loop may facilitate transfer of electrons334 Cell 129, 333–344, April 20, 2007 ª2007 Elsevier Inc.between the redox-active cysteines in Pdi1p and the
obscured active-site cysteines of Ero1p. The shuttle-
cysteine loop appears to restrict direct access of protein
substrates to the Ero1p active site, limiting nonspecific
oxidation of thiols in the ER (Sevier and Kaiser, 2006).
Here, we consider the roles of two cysteine pairs,
Cys90-Cys349 and Cys150-Cys295, that link the nonhel-
ical Ero1p cap to the helical core of the enzyme. Our
in vitro and in vivo studies show that the redox state of
these cysteine pairs, which are not direct participants in
the electron relay from reduced substrate to oxygen, influ-
ences Ero1p catalytic activity. We demonstrate that these
cysteines sense the ER oxidation state and correspond-
ingly modulate Ero1p activity, perhaps by influencing
mobility of the loop containing the shuttle cysteines. We
propose that redox regulation of Ero1p at the protein level
reflects a homeostatic regulatory system that rapidly
responds to redox conditions in the ER, allowing the cell to
maintain a redox environment favorable for native disul-
fide-bond formation.
RESULTS
Cys90-Cys349 and Cys150-Cys295 Disulfides Inhibit
Ero1p Activity
To assess the function of individual disulfide bonds in
Ero1p, we mutated each disulfide-bonded pair of cyste-
ines. Of the five known disulfides in Ero1p, only Cys100-
Cys105 and Cys352-Cys355 are essential for Ero1p
activity in vivo (Frand and Kaiser, 2000); Ero1p mutants
with alanine residues in place of Cys90-Cys349, Cys143-
Cys166, or Cys150-Cys295 are designated functional
based on their ability to complement a chromosomal de-
letion of ERO1 (Figures 1C and 1D).
For a more sensitive and direct assessment of Ero1p
cysteine mutants, we assayed the ability of wild-type and
mutant Ero1p to oxidize reduced protein substrates in vi-
tro. For our initial experiments, we used Escherichia coli
thioredoxin (Trx1), which is structurally related to physio-
logical Ero1p substrates such as Pdi1p. Trx1 is useful for
kinetic studies of Ero1p because it can be purified in
high yield and is readily oxidized by Ero1p in vitro (Gross
et al., 2006; Sevier and Kaiser, 2006). Recombinant Ero1p
(residues 56–424; Ero1p-c) (Gross et al., 2004) and
Ero1p-c mutants lacking noncatalytic cysteine pairs
(Ero1p-c-C90A-C349A, Ero1p-c-C150A-C295A, and
Ero1p-c-C143A-C166A) were purified from E. coli and
mixed with reduced Trx1 at a ratio of 1:200. Ero1p-c activ-
ity was assayed by monitoring consumption of oxygen
(which was converted to hydrogen peroxide). Strikingly,
Ero1p-c-C150A-C295A exhibited enhanced catalytic ac-
tivity toward Trx1. This mutant showed a 3-fold increase
in the maximal rate of oxygen consumption relative to
wild-type (Figure 2A), suggesting that formation of the
Cys150-Cys295 disulfide normally inhibits Ero1p activity.
The rate of oxygen consumption for Ero1p-c-C90A-
C349A was similar to that observed with wild-type
Ero1p-c (Figure 2B). Ero1p-c-C143A-C166A showed ade-
creased rate of oxygen consumption relative to wild-type,
likely due to loss of structural stability (data not shown).
When tested on Pdi1p, Ero1p-c-C150A-C295A again
showed a 3-fold increase in the maximal rate of oxygen
consumption relative to wild-type Ero1p (Figure 2C). Con-
sistent with the higher redox potential of Pdi1p relative to
Trx1 (Lundstrom and Holmgren, 1993), Ero1p-c oxidized
Pdi1p much more slowly than Trx1 (Figure 2).
When oxygen consumption during catalysis of disulfide
bond formation by Ero1p-c was monitored, a pronounced
lag phase was observed (Figure 2; Gross et al., 2006). This
lag, seen with all reducing substrates studied to date, ap-
pears to reflect an activation step required to initiate
Ero1p-c catalytic activity. Notably, the 1.5 min lag seen
in our assays with Trx1 and wild-type Ero1p-c was short-
ened to about 10 s for Ero1p-c-C150A-C295A (Figure 2A,inset). Ero1p-c-C90A-C349A showed a more modest de-
crease in the lag to1min (Figure 2B, inset). These results
suggest that the lag in oxygen consumption observed with
wild-type Ero1p-c reflects the reduction of inhibitory
Cys150-Cys295 and Cys90-Cys349 disulfides. The acti-
vation of Ero1p is likely accomplished in vitro by electron
transfer from reduced Trx1 to Cys150-Cys295 and
Cys90-Cys349.
Figure 2. Rate of Oxygen Consumption by Ero1p Increases
When Cys150 and Cys295 Are Replaced with Ala
(A and B) Oxygen consumption by Ero1p-c during reaction with re-
duced Trx1 wasmeasured. Enzyme was added at time 0. Graph insets
show an expanded view of the lag phase for wild-type Ero1p-c, which
is decreased for Ero1p-c-C90A-C349A (B) and virtually absent with
Ero1p-c-C150A-C295A (A).
(C) Oxygen consumption during oxidation of Pdi1p in the presence of
reduced glutathione (GSH) was measured after injection of Ero1p.
GSH does not serve as a direct substrate of Ero1p (note black and
orange traces) and was added to increase the amplitude of the
reaction by rereducing Pdi1p.Cell 129, 333–344, April 20, 2007 ª2007 Elsevier Inc. 335
Figure 3. Cys90-Cys349 and Cys150-Cys295 Disulfides Are Reduced during the Ero1p Reaction Cycle
Oxidation of reduced Trx1 by Ero1p-c was initiated by injecting Ero1p-c (time 0) into a reduced Trx1 solution.
(A) Oxygen consumption by Ero1p-c during the reaction with Trx1 was monitored by using an oxygen electrode. At time points indicated by dotted
lines, samples were removed and mixed with the thiol-modifying agent AMS.
(B) Proteins were resolved by nonreducing SDS-PAGE, and Ero1p-c and Trx1 were visualized by immumodetection or protein staining, respectively.
(C) Reaction of Ero1p-c cysteine mutants with reduced Trx1 was monitored as described in (B).
(D) Reaction of trypsin-cleaved Ero1p-c with Trx1 in the presence of DTT. A30 kDa species that appears only when the three noncatalytic disulfides
are simultaneously reduced is indicated by an arrow. This species is not seen when cleaved Ero1p-c is reacted with DTT alone (data not shown).
Incompletely reduced (asterisk) and oxidized (ox.) Ero1p-c are also noted.
(E) Oxidation of reduced Trx1 by Ero1p was initiated by injection of Ero1p. At various time points after reaction initiation, an additional reduced Trx1
dose was added. Data from the second injection traces were scaled and superposed. Longer lag phases correlate with increased initial reaction times
before addition of the second dose of reduced Trx1.Successive Disulfide Reduction Precedes
Ero1p Activation
To examine the redox state of Ero1p during and after the
lag in oxygen consumption, aliquots were removed from
the oxygen electrode chamber as the reaction between
Ero1p and Trx1 proceeded, and free thiols were alkylated
with 4-acetamido-40-maleimidylstilbene-2,20-disulfonic
acid (AMS). Oxidation of reduced Trx1 during the reaction
with Ero1p-c was confirmed by an increase in electropho-
retic mobility of Trx1 over time (Figure 3B). As anticipated,
Ero1p-c also underwent redox changes during reaction336 Cell 129, 333–344, April 20, 2007 ª2007 Elsevier Inc.with Trx1. Prior to substrate addition, Ero1p-c was fully
oxidized and migrated rapidly in the gel. Within 20 s of
substrate addition, a mobility shift in Ero1p-c indicated
opening of at least one disulfide (Figure 3B). This slowly
migrating Ero1p-c species was detected throughout the
lag phase, and after about 1 min, an even slower species
appeared. These reduced forms of Ero1p-c persisted until
all the substrate had been oxidized, when Ero1p-c
returned to its compact, disulfide-bonded form.
The number of added AMS moieties affects the rate
of migration of reduced Ero1p-c species, but under
nonreducing conditions, migration of partially reduced
Ero1p-c also depends on the distance in primary structure
between cysteines involved in disulfides. Reduction of
disulfide bonds linking cysteines far apart in sequence
(‘‘long-range disulfides’’), such as Cys90-Cys349 and
Cys150-Cys295 (Figure 1A), will cause the greatest in-
crease in hydrodynamic radius of the SDS-bound Ero1p-c
species and thus the greatest decrease in mobility. The
reduction of closely spaced cysteines involved in disulfide
bonds (Cys100-Cys105, Cys143-Cys166, or Cys352-
Cys355) will have a correspondingly smaller effect on
mobility. Using migration of Cys-to-Ala mutants as stan-
dards, we correlated the reduced forms of Ero1p-c ob-
served during our kinetic assays with specific disulfide re-
duction. The first reduced Ero1p-c species (observed 20 s
after Trx1 addition) comigrated with an Ero1p-c mutant
lacking Cys150-Cys295, suggesting that the initial step
of Ero1p activation was Cys150-Cys295 reduction (Fig-
ure 3B). The more slowly migrating reduced species (ap-
pearing after 1 min) likely reflects reduction of both
Cys150-Cys295 and Cys90-Cys349, because this band
migrated more slowly than both Ero1p-c-C150A-C295A
and Ero1p-c-C90A-C349A (Figure 3B). The absence of
a band comigrating with Ero1p-c-C90A-C349A suggests
that a species corresponding to reduction of Cys90-
Cys349 alone did not occur. Instead, reduction of Ero1p
appeared to take place in two steps, with reduction of
Cys150-Cys295 followed by reduction of Cys90-Cys349.
Some of the reduced species appeared as doublets,
which most likely reflects the presence or absence of
a short-range disulfide. To confirm long-range and probe
for short-range disulfide reduction in activated Ero1p-c,
Ero1p-c was incubated with reduced Trx1, blocked post-
lag by N-ethylmaleimide (NEM), and analyzed by liquid
chromatography coupled with tandem mass spectrome-
try (LC-MS/MS). At least partial NEM labeling was de-
tected for the following cysteines: Cys90, Cys143,
Cys150, Cys166, Cys295, and Cys349 (data not shown).
Analysis of Ero1pmutants unable to form one of the two
long-range disulfides, Ero1p-c-C90A-C349A and Ero1p-
c-C150A-C295A, confirmed that reduction of both
Cys150-Cys295 and Cys90-Cys349 precedes Ero1p acti-
vation. Both Ero1p-c-C90A-C349A and Ero1p-c-C150A-
C295A underwent significant migration shifts to amore re-
duced form after exposure to reduced Trx1 (Figure 3C).
Reduction of the remaining long-range disulfide in these
mutants preceded the accumulation of oxidized Trx1
(Figure 3C). Reduction of both long-range disulfides in
Ero1p-c-C100A-C105A, a mutant lacking the catalytic
shuttle cysteines, occurred with similar kinetics to wild-
type Ero1p, indicating that activation does not depend
on Ero1p activity (Figure 3C).
Although both Ero1p-c-C90A-C349A and Ero1p-
c-C150A-C295A were rapidly reduced upon exposure to
reduced Trx1, Ero1p-c-C90A-C349A showed a delay in the
production of oxidized Trx1 compared to Ero1p-c-C150A-
C295A (Figure 3C). This delay could reflect the time
required to achieve an additional conformational changenecessary for Ero1p activation. Rapid reduction of
Cys90-Cys349 in the Ero1p-c-C150A-C295A mutant (Fig-
ure 3C), relative to the delayed reduction of Cys90-Cys349
in wild-type Ero1p (Figure 3B), may indicate destabiliza-
tion of the Cys90-Cys349 disulfide when Cys150-Cys295
is absent or reduced. Such instability may be an inherent
feature of the reductive activation process, as Cys90-
Cys349 reduction in wild-type Ero1p was not observed
until Cys150-Cys295 reduction had been initiated. The
observation that reduction of both Cys90-Cys349 and
Cys150-Cys295 precedes Ero1p activation suggests
that these disulfides are ‘‘regulatory’’ bonds.
Ero1p-c lacking both Cys150-Cys295 and Cys90-
Cys349 was insoluble when expressed in E. coli and could
not be purified for use in our in vitro assays (data not
shown). The correlation between inability to form both di-
sulfides and insolubility suggests that large structural per-
turbations occur when these disulfides are absent. To
confirm that reduction of Cys90-Cys349 and Cys150-
Cys295 promotes rather than compromises enzyme activ-
ity, we took advantage of an observation that trypsin
cleaves Ero1p-c uniquely after Lys154 to produce a cata-
lytically active species comprised of two fragments (17
and 30 kDa) linked by all three noncatalytic disulfides:
Cys90-Cys349, Cys150-Cys295, and Cys143-Cys166.
Transient, simultaneous reduction of all three disulfides
during catalysis of Trx1 oxidation by trypsin-cleaved
Ero1p-c was evident by dissociation of the cleavage frag-
ments during the reaction (Figure 3D). Partial Ero1p-c re-
duction early after Trx1 addition (asterisk) and reoxidation
late in the reaction (ox.) were also detected (Figure 3D).
Ero1p Is Inactivated after Consumption of Substrate
In our in vitro kinetic assays, oxygen (>250 mM) was pres-
ent in excess of reduced Trx1 (100 mM), allowing for con-
tinual regeneration of the Ero1p active site and complete
oxidation of Trx1. Reoxidation of the regulatory disulfides
in wild-type Ero1p-c and the Ero1p-c mutants, Ero1p-
c-C90A-C349A and Ero1p-c-C150A-C295A, was appar-
ent after most of the Trx1 became oxidized in each case
(Figures 3B and 3C). Ero1p-c-C100A-C105A remained in
the reduced form after 20 min, consistent with its limited
ability to catalyze Trx1 oxidation (Figure 3C).
To test whether reoxidation of Ero1p after substrate
consumption inactivates Ero1p, we allowed recombinant
Ero1p (residues 10–424) to completely oxidize reduced
Trx1 and then, after various delay times, added a second
aliquot of reduced Trx1 (Figure 3E). When the second ali-
quot was added shortly after complete oxidation of the
first, oxidation of the second aliquot proceeded without
a lag. However, as the time between the first and second
aliquots increased, the length of the second lag phase in-
creased. Approximately 10 min were required between al-
iquots to fully restore the lag phase, which likely reflects
the time required for complete reoxidation of Ero1p. Nota-
bly, wild-type Ero1p that has already overcome the lag
(similar to the C150A-C295A mutant) shows a 2-fold
faster maximal rate of oxygen consumption relative toCell 129, 333–344, April 20, 2007 ª2007 Elsevier Inc. 337
wild-type Ero1p that still has to overcome the lag during
the course of the reaction (Figure 3E, compare 13.8 versus
2.6 min curves), suggesting that Ero1p-C150A-C295A is
accurately recapitulating the reduced, activated form
wild-type Ero1p.
Reduction of Ero1p Disulfides Correlates with ER
Redox Changes
To determine whether the redox potentials of Cys90-
Cys349 and Cys150-Cys295 are appropriate for reductive
activation of Ero1p in vivo, we followed the redox state of
these disulfides under normal and relatively reducing ER
conditions. To make the ER less oxidizing, we grew the
temperature-sensitive ero1-1 strain at the permissive tem-
perature of 24C. Under these conditions, cell growth and
disulfide formation occur, yet the ER has a diminished ox-
idative capacity, as indicated by hypersensitivity to the re-
ducing agent dithiothreitol (DTT) (Frand and Kaiser, 1998).
To decouple Ero1p expression and ER oxidation, we used
a myc-tagged catalytically inactive Ero1p-C100A-C105A
to follow the redox states of Cys90-Cys349 and Cys150-
Cys295.
To determine the redox state of Ero1p in vivo, wild-type
or ero1-1 cells containing ERO1 plasmids were grown to
exponential phase, treated with trichloroacetic acid (TCA)
and NEM to block free thiols, and Ero1p was detected by
western blotting after nonreducing SDS-PAGE (Figure 4).
Due to the small size of NEM, the migration rate of Ero1p
reflected formation or reduction of regulatory disulfide
bonds only, as indicated by migration of Ero1p as a single
band under reducing conditions. Under normal ER redox
conditions (wild-type cells), Ero1p was predominantly ox-
idized (Figure 4, lanes 1 and 2), suggesting that most cel-
lular Ero1p is catalytically inactive and implying that a low
level of Ero1p activity is sufficient to support protein oxida-
tion. Under more reducing ER conditions, a dramatic shift
in Ero1p mobility to reduced species was observed (Fig-
ure 4, lane 6). Ero1p mutants lacking Cys90-Cys349 or
Cys150-Cys295 comigrated with the reduced forms of
Ero1p, although it was not clear what accounts for the
precise disulfide connectivity of red1 and red2 (Figure 4).
Expression of functional Ero1p in the ero1-1 strain back-
ground resulted in a compact oxidized Ero1p band similar
to that observed inwild-typecells (Figure 4, lane5 versus 1).
Overexpression of Ero1p-C150A-C295A Inhibits
Cell Growth
Overexpression of wild-type Ero1p results in increased
oxidized glutathione production and confers resistance
to DTT yet does not appear to be a major source of oxida-
tive stress to cells (Cuozzo and Kaiser, 1999; Frand and
Kaiser, 1998). Our in vitro and in vivo studies indicated
that under oxidizing conditions wild-type Ero1p was inac-
tivated, whichmight prevent detrimental hyperoxidation of
the ER. To test the effect of partially deregulated Ero1p
mutants on cell function, we overexpressed Ero1p
mutants unable to form the Cys90-Cys349 or Cys150-
Cys295 disulfides. Overexpression of Ero1p-C150A-338 Cell 129, 333–344, April 20, 2007 ª2007 Elsevier Inc.C295A caused a marked growth inhibition (Figure 5A),
whereas strains overexpressing wild-type Ero1p, Ero1p-
C90A-C349A, or Ero1p-C143A-C166A grew as well as a
control strain containing empty vector (Figure 5 and data
not shown). Overexpression of Ero1p lacking both Cys90-
Cys349 and Cys150-Cys295 resulted in a growth defect
less pronounced than that observed with the Cys150-
Cys295 mutant alone (data not shown). Based on the in-
solubility of this quadruple mutant expressed in E. coli, the
decreased toxicity in yeast cells may reflect a decreased
specific activity due to folding defects.
To follow the viability of cells after extended (4, 8, or 12
hr) overexpression of wild-type or mutant Ero1p, equiva-
lent OD600 units of cells were assayed for viable colonies
by plating on glucose medium. A dramatic decrease in
the number of viable cells was observed beginning 8 hr
postinduction of Ero1p-C150A-C295A (Figure 5D). The vi-
ability of cells expressing Ero1p or Ero1p-C90A-C349A
was also moderately decreased, which may reflect some
toxicity from Ero1p and Ero1p-C90A-C349A activity or
toxicity from an increased protein load in the ER due to
Ero1p overexpression (Figure 5D).
The slow growth caused by Ero1p-C150A-C295A over-
expression was more pronounced in an ire1D mutant
strain, which is not able to induce the unfolded protein re-
sponse (UPR), suggesting that the UPRmay help alleviate
the negative impact of Ero1p-C150A-C295A (Figure 5B).
Ero1p-C150A-C295A overexpression elicits a modest in-
duction of the UPR; 6 hr post Ero1p-C150A-C295A induc-
tion in a wild-type (IRE1+) strain, a 2-fold induction of the
UPR (relative to cells with empty vector) was detected
by using an UPRE-lacZ reporter. As a point of reference,
a wild-type strain exposed to tunicamycin (5 mg/ml) for 6
hr caused a 10-fold induction of the UPR (data not shown).
Figure 4. Cys90-C349 and Cys150-Cys295 Disulfides Are
Reduced When the ER Oxidizing Capacity Is Decreased
CKY263 or CKY598 containing pAF82, pCS56, pCS481, or pCS483
was grown in SMM at 30C or 24C, respectively. The oxidation state
of Ero1p was assessed after resolving NEM-modified cellular proteins
by nonreducing or reducing SDS-PAGE and immunoblotting (anti-myc).
Figure 5. Overexpression of Ero1p-C150A-C295A Inhibits Cell Growth
(A) Growth curves of CKY263 or (B and C) CKY1026 transformants. Cells containing pAF112, pCS450, pCS452, pCS504, or empty vector were grown
at 30C in SMM Raf, subcultured in SMM Gal, and sampled hourly for OD measurements at 600 nm.
(D) To determine the viability of the strains in (A), 13 104 OD units of cells were spread onto SMM plates and incubated for 2 days at 30C. Colony-
forming units recovered 8 or 12 hr post Ero1p induction are expressed as percent colonies relative to 0 hr plate.
(E) After 5 hr of induction in CKY1026, the oxidation states of overexpressed Ero1 proteins were determined bywestern blotting (anti-myc) AMS-mod-
ified cellular proteins, resolved on nonreducing SDS-PAGE. Identical results were observed with Ero1 proteins overexpressed in CKY263 (data not
shown). Reduced Ero1p migration standards were prepared by reducing cellular proteins with DTT prior to AMS treatment.Overexpression of an Ero1p mutant lacking both
Cys150-Cys295 and the shuttle cysteines (Cys100 and
Cys105) was not detrimental to cell growth (Figure 5C).
This result shows that the negative effect on growth de-
pends on Ero1p catalytic activity. The absence of a growth
defect with Ero1p-C100A-C105A-C150A-C295A also
demonstrates that Ero1p-C150A-C295A uses the same
catalytic cycle previously characterized for wild-type
Ero1p (Frand and Kaiser, 2000; Sevier and Kaiser, 2006).
Overexpressed Ero1p-C150A-C295A
Is in a Reduced, Activated State
To determine the redox state of overexpressed Ero1p,
cells were harvested 5 hr after induction, treated with TCA
and AMS to preserve thiol connectivity, and the overex-
pressed form of Ero1p was detected by immunoblotting
for the myc-epitope after nonreducing SDS-PAGE (Fig-ure 5E). Ero1p, Ero1p-C90A-C349A, and Ero1p-C150A-
C295A migrated at different rates under nonreducing
conditions, reflecting differences in disulfide connectivity
(Figure 5E, lanes 1–3). When cell extracts were treated
with DTT (to reduce all disulfides) prior to AMS, Ero1p and
Ero1p-C90A-C349A shifted to a slower-migrating form,
indicating that both proteins contained at least one regu-
latory disulfide (Figure 5E, lanes 1 and 2 versus lanes 4
and 5). Themobility of Ero1p-C150A-C295A did not signif-
icantly change upon DTT treatment, suggesting that the
only regulatory disulfide in this mutant (Cys90-Cys349)
was reduced prior to DTT addition (Figure 5E, lane 3 ver-
sus lane 6). After DTT treatment, Ero1pmigrated as a dou-
blet (Figure 5E), which may reflect partial reduction of a
short-range disulfide.
The different growth phenotypes observed after Ero1p-
C90A-C349A and Ero1p-C150A-C295A overexpressionCell 129, 333–344, April 20, 2007 ª2007 Elsevier Inc. 339
Figure 6. Ero1p-C150A-C295A Exhibits Increased Oxidative Capacity In Vivo
(A–C) Growth curves of CKY1026 transformants; see Figure 5 for details. (A and B) Oxidized (ox.) or reduced (red.) DTT or (C) BSO was added at 0 hr.
(D) After 5 hr in SMMGal, with or without BSO, the oxidation state of Ero1p-C150A-C295A was followed by resolving AMS-modified cellular proteins
on nonreducing SDS-PAGE and immunoblotting with anti-myc. Reduced Ero1p-C150A-C295A was prepared by adding DTT to cells prior to AMS.
After 5 hr of BSO treatment, total cellular glutathione levels were 15% of untreated cells (data not shown).
(E) The impact of Ero1p-C150A-C295A overexpression on cellular oxidized glutathione (GSSG) levels was determined by using a whole-cell assay to
follow GSSG regeneration, after reduction of cellular GSSG by DTT. Glutathione levels were assayed in CKY263 cells containing empty vector,
pAF112, or pCS452. Cellular GSSG:GSH ratios are plotted as a function of time after DTT removal. White-filled data points represent cellular
GSSG:GSH ratios measured immediately prior to DTT treatment.can be explained by the redox state of the regulatory disul-
fides in these mutants. For Ero1p-C150A-C295A, Cys90-
Cys349 appears to be reduced, consistent with enhanced
catalytic activity, hyperoxidation of the ER, and cellular
toxicity (Figures 3 and 5). In contrast, for Ero1p-C90A-
C349A, the single regulatory Cys150-Cys295 disulfide re-
mains oxidized, thus inactivating Ero1p and preventing
hyperoxidation of the ER (Figure 5). For wild-type Ero1p,
both Cys90-Cys349 and Cys150-Cys295 are oxidized,
and overproduced Ero1p appears inactive (Figure 5). The
correlation between overexpression-induced toxicity and
the absence of both regulatory disulfides suggests that re-
duction or loss of an individual regulatory disulfide is not
sufficient for Ero1p activation.
Ero1p-C150A-C295A Exhibits Increased Activity
In Vivo
To confirm that the growth defect from Ero1p-C150A-
C295A overexpression was a consequence of increased
Ero1p activity, we examined whether the negative effect
of overexpression could be counteracted by a reducing340 Cell 129, 333–344, April 20, 2007 ª2007 Elsevier Inc.agent. To prevent induction of UPR target genes upon ex-
posure to reducing agent, these experiments were done in
an ire1D strain (Travers et al., 2000). Addition of reduced
DTT to the growth medium upon Ero1p-C150A-C295A in-
duction resulted in a growth rate similar to that observed
with a strain overexpressing wild-type Ero1p (Figure 6A).
Rescue was not observed when the equivalent concentra-
tion of oxidized DTT was added (Figure 6A). Notably, the
optimal DTT concentration for rescue of the growth defect
(0.5mM) is toxic to cells not overexpressing Ero1p; the ox-
idative activity of wild-type or mutant Ero1p counteracts
the toxicity caused by the reducing agent (Figure 6B).
To more directly examine the impact of Ero1p-C150A-
C295A overexpression on the ER redox environment, we
followed the rate of glutathione oxidation in yeast cells
overexpressing Ero1p or Ero1p-C150A-C295A. The ratio
of oxidized to reduced glutathione is 30- to 100-fold
greater in the ER than in the cytosol (Hwang et al., 1992),
suggesting that most oxidized glutathione detected in an
assay of whole cells is located in the ER. We assayed ox-
idized glutathione (GSSG) production by pulsing cells with
Figure 7. Model for the Modulation of
Ero1p Activity in Relation to the ER Re-
dox Environment
(A) The regulatory and catalytic cysteines of
Ero1p are depicted as white and black ovals. (A
and B) By tethering the nonhelical cap to the
protein core, formation of Cys90-Cys349 and
Cys150-Cys295 may restrict the functional
dynamics of the loop containing the shuttle
cysteines (Cys100-Cys105) and decrease
Ero1p activity. When the regulatory disulfides
are reduced, active Ero1p uses molecular oxy-
gen to facilitate protein oxidation via Pdi1p.reduced DTT to lower GSSG levels and subsequently fol-
lowing the rate of GSSG regeneration after DTT removal.
As anticipated from previous studies (Cuozzo and Kaiser,
1999), overexpression of Ero1p slightly enhanced the rate
of GSSG regeneration relative to a strain containing empty
vector (Figure 6E). However, overexpressing Ero1p-
C150A-C295A substantially increased the rate of GSSG
regeneration (Figure 6E). Notably, the initial GSSG:GSH
ratio prior to DTT treatment was also shifted toward the
more oxidized state in a strain overexpressing Ero1p-
C150A-C295A (Figure 6E). These data confirm that over-
expression of the hyperactive Ero1p shifts the ER redox
environment to a more oxidizing state.
Surprisingly, lowering cellular glutathione levels by
treatment with the GSH1 inhibitor buthionine sulfoxide
(BSO) alleviated the growth defect from Ero1p-C150A-
C295A overexpression (Figure 6C). As glutathione has
been shown to buffer against hyperoxidizing conditions
(Cuozzo and Kaiser, 1999), it was initially expected that
lowering glutathione levels would exacerbate the growth
defect. Examination of the redox state of Ero1p-C150A-
C295A in cells treated with BSO revealed a shift in Ero1p-
C150A-C295A mobility to the oxidized, inactive species
(Figure 6D). We suggest that inactivation of the hyperac-
tive Ero1p mutant when glutathione is depleted prevents
hyperoxidation of the ER, which outweighs the potential
negative impact of diminished redox buffer. These data
suggest that glutathione normally has a role in reducing
and activating Ero1p. The fact that Ero1p-C150A-C295A
can be inactivated by oxidation of Cys90-Cys349 con-
firms that both regulatory disulfides must be reduced to
activate Ero1p.
DISCUSSION
We have demonstrated that two cysteine pairs in Ero1p,
Cys90-Cys349 and Cys150-Cys295, affect Ero1p activity
in a redox-dependent manner. When these cysteines are
in the thiol (reduced) form, Ero1p is catalytically active;
when they are in the disulfide (oxidized) form, Ero1p is in-
active (Figure 7B). Our data suggest that posttranslational
regulation of Ero1p activity governs the flow of oxidizing
equivalents to the ER thiol pool, allowing the cell to main-
tain ER redox conditions favorable for native disulfide
formation.Homeostatic Control of Disulfide-Bond Formation
Wepropose that Ero1p regulation is part of a feedback cir-
cuit wherein changes in the ER redox environment are off-
set by modulation of Ero1p activity. If the ER becomes too
oxidizing, the regulatory cysteine pairs of Ero1p become
disulfide bonded, decreasing Ero1p activity and lessening
the flow of oxidizing equivalents to protein thiols in the
ER. Conversely, if the concentration of free thiols in the
ER rises, the Ero1p regulatory disulfides are reduced, in-
creasing enzyme activity and promoting disulfide-bond
formation. The elegant simplicity of this system is the
competition between dithiol substrates and the Ero1p reg-
ulatory dicysteine motifs themselves for Ero1p activity.
Sufficient substrate availability maintains Ero1p in a re-
duced functional state. In the absence of substrates,
Ero1p may catalyze oxidation of its own regulatory disul-
fides, effecting its own inactivation either in cis or in trans.
This homeostatic system would be expected to buffer
against fluctuations in the concentrations of thiol species
in the ER as well as to dampen any effects of nonoptimal
levels of Ero1p.
We observed a marked decrease in growth and viability
of cells overexpressing an Ero1p mutant lacking one of
the regulatory disulfides, Ero1p-C150A-C295A. Although
the possibility that this mutant has some neomorphic hy-
peractive oxidative properties beyond those observed
with reduced wild-type Ero1p cannot be excluded, we
suggest that the toxic effects from Ero1p-C150A-C295A
overexpression are the direct result of the mutant mimick-
ing the activated state of Ero1p and constitutive hyperac-
tive catalytic function (Figures 5 and 6). Toxicity is likely
a result of reactive oxygen species (ROS) accumulated
during continual cycles of Ero1p oxidation and reduction,
during which oxygen is consumed and hydrogen peroxide
is produced. Tight control of Ero1p activity may minimize
ROS production, especially under relatively oxidizing con-
ditions when less reduced glutathione may be available to
scavenge peroxide species.
Candidate redox-active species in the ER that may reg-
ulate Ero1p activity include reduced Pdi1p, Pdi1p homo-
logs, and glutathione. Although reduced glutathione is
a poor substrate of Ero1p (Sevier and Kaiser, 2006; Tu
et al., 2000) and does not directly activate Ero1p in vitro
(data not shown), cellular glutathione levels do influence
the redox status and catalytic activity of Ero1p. DepletingCell 129, 333–344, April 20, 2007 ª2007 Elsevier Inc. 341
cellular glutathione by blocking glutathione synthesis re-
sulted in the oxidation of Ero1p-C150A-C295A, which was
otherwise in the reduced state (Figure 6D). A potential ex-
planation for the impact of glutathione on the redox state
of Ero1p-C150A-C295A is that low glutathione levels may
fail to reduce Pdi1p and/or related ER proteins, preventing
them from activating Ero1p.
Mechanisms for Maintaining Redox Balance
in Eukaryotes versus Bacteria
Oxidative protein folding in bacteria occurs in the periplas-
mic space, where disulfide formation is catalyzed by the
transmembrane protein DsbB and the soluble periplasmic
protein DsbA (reviewed by Kadokura et al. [2003]). Also
present in the bacterial periplasm are the transmembrane
protein DsbD and its soluble partner DsbC, which consti-
tute a pathway for reduction or isomerization of mispaired
cysteines (reviewed in Messens and Collet [2006] and
Porat et al. [2004]). A major question in the study of oxida-
tive protein folding in bacteria was how the oxidation and
reduction pathways are kinetically isolated from one an-
other such that the two competing pathways can operate
simultaneously in the same compartment (Rozhkova et al.,
2004). The answer appears to be structural: steric incom-
patibility between the soluble component of one pathway
and the membrane-embedded component of the oppos-
ing pathway (Bader et al., 2001; Inaba et al., 2006; Sega-
tori et al., 2006).
In eukaryotes, the oxidation and reduction pathways
appear not to utilize different oxidoreductases but rather
to converge on Pdi1p. The redox state of Pdi1p, and con-
sequently its function, may be tuned by regulating Ero1p
activity. Accumulation of more Pdi1p in the reduced state
when Ero1p activity is compromised may increase the
amount of Pdi1p available to act as a reductase or isom-
erase (Frand and Kaiser, 1999). Favoring reduced Pdi1p
may be advantageous under hyperoxidizing conditions
to promote the reshuffling of nonnative disulfide bonds ac-
cumulated during oxidative stress. The enhanced chaper-
one activity of reduced Pdi1p may also stimulate the un-
folding, dislocation and degradation of misfolded ER
proteins (Tsai et al., 2001). Using feedback regulation of
Ero1p to tightly control the redox state of Pdi1p solves
the challenge of simultaneously maintaining oxidized and
reduced pools of oxidoreductase in the ER, providing a so-
lution distinct from the kinetically isolated pathways of the
bacterial periplasm.
Structural Basis for Ero1p Redox Regulation
The availability of a crystal structure of Ero1p allows us to
speculate on the mechanism by which the regulatory di-
sulfides influence Ero1p catalytic activity. It has been sug-
gested previously that movement of the region containing
the catalytic shuttle cysteines facilitates electron transfer
from Pdi1p to the Ero1p active site (Gross et al., 2004). In-
triguingly, the Cys90-Cys349 and Cys150-Cys295 disul-
fides connect the nonhelical cap, in which the shuttle cys-
teines are located, with the helical core of Ero1p (Figure 1;342 Cell 129, 333–344, April 20, 2007 ª2007 Elsevier Inc.Gross et al., 2004). By tethering the loops of the cap to the
protein core, the regulatory disulfides may restrict loop
mobility, thus decreasing Ero1p activity (Figure 7).
We suggest that phenotypic differences between the
Ero1p-C90A-C349A and Ero1p-C150A-C295A mutants
do not indicate a greater importance for Cys150-Cys295
in the control Ero1p activity but rather reflect interdepen-
dence of the two cysteine pairs. Differences in Ero1p acti-
vation and catalytic function observed with these alleles
can be explained by three considerations: (1) Ero1p is fully
active only when both regulatory bonds are reduced, (2)
the Cys90-Cys349 bond is unstable when the Cys150-
Cys295 bond is absent, and (3) the stability of the
Cys150-Cys295 bond is not significantly influenced by
Cys90-Cys349. Accordingly, for the Ero1p-C150A-C295A
mutant, Cys90-Cys349 is easily reduced and themutant is
constitutively active, whereas the Ero1p-C90A-C349A
mutant still displays redox-dependent feedback inhibition
due to oxidation of Cys150-Cys295.
Putative Regulatory Disulfides in Ero1p Orthologs
The presence in Ero1p homologs of multiple cysteine res-
idues in addition to those directly involved in catalysis sug-
gests the potential for redox regulation of Ero1 proteins in
multicellular organisms. A Cys90-Cys349 equivalent is
found in all but one of the Ero1p homologs (Encephalito-
zoon cuniculi) and likely forms a conserved regulatory di-
sulfide. In contrast, the Ero1p Cys150-Cys295 disulfide
is less conserved. Most fungal homologs share a position-
ally conserved Cys150-Cys295 pair, yet Ero1 proteins
from multicellular eukaryotes appear to lack a Cys150-
Cys295 equivalent. Perhaps Cys150-Cys295 evolved
as a regulatory disulfide uniquely suited to respond to
changes in the ER environment of fungi. Alternatively,
the regulatory function of Cys150-Cys295 could be ac-
complished in other organisms by a disulfide in a different
position. Ero1 proteins from multicellular eukaryotes con-
tain an additional cysteine residue four residues down-
stream of the second shuttle cysteine, which has the po-
tential to form a disulfide bond with the helical core
region. Human Ero1-La migrates on nonreducing gels as
three distinct redox isoforms (R, Ox1, and Ox2) (Benham
et al., 2000). In agreement with the potential for two
long-range loop-to-core disulfides in Ero1-La, it has been
speculated that the Ox1 isoform reflects the formation of a
Cys90-Cys349 equivalent disulfide (Cys85-Cys391) and
Ox2 reflects the formation of both Cys85-Cys391 and an
additional disulfide bond (Bertoli et al., 2004).
Regulation of Ero1 activity in higher eukaryotes could
play an important role during cell growth and differentia-
tion. For example, increased thiol content as a conse-
quence of enhanced secretory capacity could activate
Ero1 and help facilitate IgM subunit assembly during
plasma cell differentiation. Development of assays similar
to those described herein for yeast Ero1p should enable
the study of mammalian Ero1 regulation. Further investi-
gations making use of these new tools in both yeast and
human cells should identify the intracellular signals that
regulate Ero1 activity and eukaryotic disulfide bond
formation.
EXPERIMENTAL PROCEDURES
Saccharomyces cerevisiae strains were grown and genetically manip-
ulated by using standard techniques (Adams et al., 1998). SMM, SMM
Gal, and SMM Raf are synthetic minimal media containing 2% glu-
cose, galactose, or raffinose. Uracil or leucine media supplements
were removed to select for plasmids as needed.
Strains and Plasmid Construction
Plasmids pAF82 [CEN URA3 ERO1-myc], pAF85 [CEN LEU2 ERO1-
myc], and pCS169 [CEN LEU2 ero1-C100A-C105A-myc] are de-
scribed in Frand and Kaiser (1998) and Sevier and Kaiser (2006). Plas-
mid pAF112 is pAF82 with a GAL1 promoter in place of the 50 ERO1
UTR (Frand and Kaiser, 1998). To create CEN URA3 ERO1-myc plas-
mids pCS56 [ero1-C100A-C105A], pCS481 [ero1-C90A-C100A-
C105A-C349A], pCS483 [ero1-C100A-C105A-C150A-C295A],
pCS450 [PGAL1-ero1-C90A-C349A], pCS452 [PGAL1-ero1-C150A-
C295A], pCS504 [PGAL1-ero1-C100A-C105A-C150A-C295A], and
CEN LEU2 ERO1-myc plasmids pCS294 [ero1-C352A-C355A],
pCS430 [ero1-C90A-C349A], pCS523 [ero1-C143A-C166A], and
pCS524 [ero1-C150A-C295A], amino acid replacements were made
in pAF82, pAF112, or pAF85 by QuikChange site-directed mutagene-
sis (Stratagene) or by subcloning mutations from previously con-
structed ERO1 plasmids using standard techniques.
Plasmids encoding glutathione S-transferase (GST) fused to a His6-
tagged Ero1p (residues 56–424; Ero1p-c), GST-tagged Ero1p (resi-
dues 10–424), and His6-tagged thioredoxin (Trx1) or Pdi1p have
been described (Gross et al., 2004, 2006; Sevier et al., 2001). Ero1p-c
mutant plasmids pCS410 [ero1-c-C90A-C349A] and pCS425 [ero1-c-
C150A-C295A] were constructed by mutagenesis.
CKY598 (ero1-1) and CKY933 (ero1D [pAF82]) strains are described
in Frand and Kaiser (1998) and Sevier and Kaiser (2006). CKY1026
(ire1D) was made by one-step gene replacement of IRE1 with KanMX
in CKY263 (MATa GAL2 ura3-52 leu2-3,112). CKY1027, CKY1028,
CKY1029, and CKY1030 strains were generated by transformation of
CKY933 with pAF85, pCS430, pCS523, or pCS524, followed by selec-
tion against pAF82 by plating on SMMwith 5-fluoroorotic acid (5-FOA;
Toronto Research Laboratories, Downsview, Ontario, Canada).
Expression and Purification of Ero1p, Trx1, and Pdi1p
GST-tagged Ero1p (residues 10–424) was purified as described (Gross
et al., 2006). Ero1p-c, Trx1, and Pdi1p were expressed and purified es-
sentially as described (Sevier et al., 2001; Sevier and Kaiser, 2006).
Oxygen Consumption and Ero1p Oxidation State In Vitro
Reduced Trx1 was prepared by incubation of purified Trx1 with 50mM
DTT for 1 hr at room temperature. Trx1 and DTT were separated by us-
ing a PD-10 column equilibrated in buffer A (50 mM potassium phos-
phate [pH 7.5], 65mMNaCl, and 0.5mMEDTA). Column fractions con-
taining reduced Trx1 were pooled, and the concentration of reduced
Trx1 was calculated with Ellman’s reagent.
Oxygen consumption was measured in a 1.0 ml volume by using an
Oxygraph Clark-type oxygen electrode (Hansatech Instruments). Re-
duced Trx1 was diluted to 100 mM in buffer A, and oxygen levels
were monitored until a linear baseline was established, at which time
the reaction was initiated by injection of 50 ml of 10 mM Ero1p-c (0.5
mM final). For reactions with Pdi1p, Pdi1p was diluted to 100 mM in
buffer A with 10 mM GSH, and Ero1p-c was added to a final concen-
tration of 2 mM. To determine the oxidation states of Ero1p-c and Trx1
during their reaction, 10 ml samples were removed and immediately
mixed with an equal volume of 2X sample buffer (160 mM Tris-HCl
[pH 6.8], 20% glycerol, 4% SDS, and bromphenol blue) containing 2
mM AMS (Molecular Probes). The samples were incubated at roomtemperature for 30 min prior to electrophoresis on a 15% SDS-poly-
acrylamide gel. To detect Trx1, the gel was stained with Coomassie
blue or transferred to nitrocellulose and stainedwith Ponceau S. To de-
tect Ero1p-c, the gel was transferred to nitrocellulose and probed with
anti-Ero1 serum. Antiserum to Ero1p was obtained by injection of
Ero1p-c protein into rabbits by Covance, Inc. (Denver, PA).
To prepare trypsin-cleaved Ero1p-c, 30 mM Ero1p-c was incubated
with 12.5 mg/ml trypsin (Sigma) in 10 mM Tris-HCl (pH 8.5), 25 mM
NaCl for 1 hr at room temperature followed by addition of 1:100 v/v
phenylmethylsulphonylfluoride in isopropanol. Reaction with Trx1
(50 mM) was conducted with 5 mM cleaved Ero1p-c to facilitate visual-
ization of enzyme fragments and 1 mM DTT (a poor substrate for the
enzyme but a rapid reductant of oxidized Trx1) to retain the 1:200
enzyme:substrate ratio and extend the reaction time. The trypsin
cleavage site in Ero1p-c was determined by N-terminal peptide
sequencing of the 30 kDa fragment blotted from a reducing gel
onto polyvinylidene fluoride membrane.
To follow the rate of inactivation of Ero1p, the longer Ero1p construct
(residues 10–424) was used. Enzyme was injected to a 0.5 mM final
concentration into the oxygen electrode reaction chamber containing
50 mM reduced Trx1 in buffer A. At the indicated times following Ero1p
injection, 40 ml of a 1.34 mM reduced Trx1 solution was injected. The
second oxygen consumption curves were scaled between 1 and
0 and superposed from the time of the second injection.
Growth Curves
CKY263 or CKY1026 cells containing PGAL1-ERO1-myc plasmids or
empty vector were grown overnight at 30C in SMM Raf, subcultured
the following morning to an OD600 of 0.2 in SMM Gal, and returned to
30C. Drug treatments (0.5mMDTT or 5.0mMBSO) were added to the
cultures at the time of subculturing. Cultures were sampled hourly for
OD measurements at 600 nm.
CPY Radiolabeling and Immunoprecipitation
CKY1027, CKY1028, CKY1029, or CKY1030 cells were grown to ex-
ponential phase, and cells were harvested and suspended at 5
OD600 units/ml in SMM lacking methionine. Cells were labeled at
30C for 7 min with [35S]methionine and chased for 0 to 15 min with
cold methionine. Cell lysis and immunoprecipitation of CPYwere com-
pleted as described (Sevier and Kaiser, 2006).
Oxidized Glutathione Regeneration
CKY263 cells containing pAF112, pCS452, or vector were grown over-
night at 30C in SMMRaf and subcultured the following morning in the
same medium to an OD600 of 0.1. After 3.5 hr at 30
C, galactose (2%
final) was added and the cells were returned to 30C for 3 hr. Cultures
were treated with 10 mMDTT for 15 min at 30C to reduce intracellular
GSSG. DTT was removed by filtering, and cells were suspended in
fresh SMMRaf Gal. At various times after DTT removal, cells were col-
lected by centrifugation and suspended in ice-cold 1% sulfosalicyclic
acid to prevent further oxidation. Cells were lysed, and glutathione
levels were measured as described (Cuozzo and Kaiser, 1999). All
strains showed similar increases in both OD600 and total glutathione
levels throughout the recovery period.
Assays for Ero1 Oxidation State
CKY263 or CKY598 cells containing pAF82, pCS56, pCS481, or
pCS483 were grown to exponential phase at 24C or 30C in SMM.
CKY1026 cells containing pAF112, pCS450, or pCS452 were subcul-
tured from SMM Raf into SMM Gal to an OD600 of 0.2 and were grown
for 5 hr at 30C. Cells were collected and suspended in 10% (w/v) TCA,
lysed by agitation with glass beads, and proteins were collected by
centrifugation at 4C. For a subset of samples, protein pellets were re-
suspended in medium with 50 mM DTT for 15 min and proteins were
reprecipitated with TCA. For a typical experiment, a protein pellet
from 5 OD600 units of cells was suspended in 50 ml of 1X sample buffer
with 50 mMNEM and a protease inhibitor cocktail (Roche), and the pHCell 129, 333–344, April 20, 2007 ª2007 Elsevier Inc. 343
of the samples was adjusted by gradual addition of 1 M Tris-HCl (pH
8.0) until samples turned blue. Samples were incubated on ice for 30
min and boiled for 2 min. The pH of the samples was lowered by addi-
tion of sodium citrate (pH 5.5) to a final concentration of 67 mM, and
samples were treated with 250 units endoglycosidase H (NEB) for 60
min at 37C. Insoluble material was removed by centrifugation, sam-
ples were resolved by nonreducing SDS-PAGE and transferred to
nitrocellulose, and Ero1p was detected with anti-myc (9E10).
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